1,786
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

An Investigation into the Powder Release Behavior from Capsule-Based Dry Powder Inhalers

, , , , &
Pages 902-911 | Received 24 Apr 2015, Accepted 06 Aug 2015, Published online: 04 Sep 2015

Figures & data

FIG. 1. Relationship between airflow rate and generated pressure drop for low- (LR) and high-resistance (HR) RS01® inhalers, with and without a capsule. Coefficient of correlation values were greater than 0.996 for all regression lines.

FIG. 1. Relationship between airflow rate and generated pressure drop for low- (LR) and high-resistance (HR) RS01® inhalers, with and without a capsule. Coefficient of correlation values were greater than 0.996 for all regression lines.

TABLE 1 Pressure drop measurements, with and without capsule, for low-resistance (LR) and high-resistance (HR) RS01® inhalers at 30, 60, and 90 L min−1 flow rate

FIG. 2. Emitted dose as a function of pressure drop for low- and high-resistance RS01® inhalers (n = 5; mean ± SD).

FIG. 2. Emitted dose as a function of pressure drop for low- and high-resistance RS01® inhalers (n = 5; mean ± SD).

FIG. 3. Influence of flow rate and presence of a capsule on the mean cumulative volumetric particle size distributions of aerosolized mannitol powder measured from Malvern Spraytec® at (a) 30, (b) 60, and (c) 90 L min–1 (n = 3).

FIG. 3. Influence of flow rate and presence of a capsule on the mean cumulative volumetric particle size distributions of aerosolized mannitol powder measured from Malvern Spraytec® at (a) 30, (b) 60, and (c) 90 L min–1 (n = 3).

TABLE 2 Corresponding volume medium diameter (X50) of aerosolized dose measured from Malvern Spraytec® (n = 3; mean ± SD) without and with capsule

FIG. 4. Typical example illustrating changes in X50 transmission profiles of mannitol powder dispersed with and without capsule from the low-resistance RS01® inhaler at 90 L min–1.

FIG. 4. Typical example illustrating changes in X50 transmission profiles of mannitol powder dispersed with and without capsule from the low-resistance RS01® inhaler at 90 L min–1.

FIG. 5. Typical example showing the obscuration profiles of mannitol powder dispersed with and without capsule from low resistance at 90 L min–1.

FIG. 5. Typical example showing the obscuration profiles of mannitol powder dispersed with and without capsule from low resistance at 90 L min–1.

TABLE 3 Powder obscuration data tabulating %PO and tpo parameters (n = 3; mean ± SD)

TABLE 4 Dependency values and coefficient correlation for each estimated parameter for the initial release and single-decay rate models (n = 3; mean ± SD)

FIG. 6. Initial obscuration profiles of individual experiments from the low-resistance RS01® at 90 L min–1 (a) without, and (b) with a capsule.

FIG. 6. Initial obscuration profiles of individual experiments from the low-resistance RS01® at 90 L min–1 (a) without, and (b) with a capsule.

FIG. 7. Influence of pressure drop on the estimated rate constant parameters for (a) time constant, tempty, and (b) single-decay rate constant, Kdm (n = 3; mean ± SD).

FIG. 7. Influence of pressure drop on the estimated rate constant parameters for (a) time constant, tempty, and (b) single-decay rate constant, Kdm (n = 3; mean ± SD).

FIG. 8. Scatter plots showing the effect of estimated parameters (a) tempty, and (b) Kdm on X50 from the low- and high-resistance RS01®.

FIG. 8. Scatter plots showing the effect of estimated parameters (a) tempty, and (b) Kdm on X50 from the low- and high-resistance RS01®.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.